对于某些麻风反应患者，是否应考虑预防性治疗耶氏肺孢子菌肺炎？
Should prophylaxis against Pneumocystis jirovecii pneumonia be considered in selected patients with leprosy reactions?
作者信息
Ramírez-Perea Nuria, Moran-Castaño Claudia, Perez-Molina Jose A
机构信息
Internal Medicine Department, Elda University Hospital, Alicante, 03600, Spain.
Internal Medicine Department, Carmen y Severo Ochoa Hospital, Asturias, Spain.
出版信息
Pneumonia (Nathan). 2024 Apr 5;16(1):6. doi: 10.1186/s41479-024-00127-x.
Abstract
Leprosy reactions often require prolonged high-dose steroids or immunosuppressive drugs, putting patients at risk of Pneumocystis jirovecii pneumonia (PJP). However, no PJP cases are reported, possibly due to dapsone treatment for leprosy. In patients with leprosy reactions not receiving dapsone because of toxicity or resistance and requiring long-term immunosuppression, PJP prophylaxis should be considered.
摘要
麻风反应通常需要长期使用大剂量类固醇或免疫抑制药物，这使患者有患耶氏肺孢子菌肺炎（PJP）的风险。然而，尚未有PJP病例的报告，这可能归因于麻风病的氨苯砜治疗。对于因毒性或耐药性未接受氨苯砜治疗且需要长期免疫抑制的麻风反应患者，应考虑进行PJP预防。
相似文献
1
Should prophylaxis against Pneumocystis jirovecii pneumonia be considered in selected patients with leprosy reactions?对于某些麻风反应患者，是否应考虑预防性治疗耶氏肺孢子菌肺炎？
Pneumonia (Nathan). 2024 Apr 5;16(1):6. doi: 10.1186/s41479-024-00127-x.
2
Dapsone safety in hematology patients: Pathways to optimizing Pneumocystis jirovecii pneumonia prophylaxis in hematology malignancy and transplant recipients.氨苯砜在血液病患者中的安全性：优化血液系统恶性肿瘤和移植受者预防耶氏肺孢子菌肺炎的途径。
Transpl Infect Dis. 2018 Dec;20(6):e12968. doi: 10.1111/tid.12968. Epub 2018 Aug 4.
3
High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era.在现代，异基因造血细胞移植受者中肺孢子菌肺炎的发病率很高。
Cytotherapy. 2020 Jan;22(1):27-34. doi: 10.1016/j.jcyt.2019.11.002. Epub 2019 Dec 27.
4
Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation.回顾性分析异基因造血干细胞移植中静脉注射喷他脒预防肺孢子菌肺炎的效果
Transpl Infect Dis. 2016 Feb;18(1):63-9. doi: 10.1111/tid.12486. Epub 2016 Jan 30.
5
Pneumocystis jirovecii pneumonia (PJP) prophylaxis patterns among patients with rheumatic diseases receiving high-risk immunosuppressant drugs.风湿性疾病患者接受高危免疫抑制剂治疗时，肺孢子菌肺炎（PJP）的预防模式。
Semin Arthritis Rheum. 2019 Jun;48(6):1087-1092. doi: 10.1016/j.semarthrit.2018.10.018. Epub 2018 Nov 3.
6
Is cotrimoxazole prophylaxis against Pneumocystis jirovecii pneumonia needed in patients with systemic autoimmune rheumatic diseases requiring immunosuppressive therapies?对于需要免疫抑制治疗的系统性自身免疫性风湿病患者，是否需要复方磺胺甲噁唑预防卡氏肺孢子虫肺炎？
Rheumatol Int. 2021 Aug;41(8):1419-1427. doi: 10.1007/s00296-021-04808-4. Epub 2021 Mar 3.
7
Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.非HIV感染人群中的耶氏肺孢子菌肺炎
Ann Pharmacother. 2016 Aug;50(8):673-9. doi: 10.1177/1060028016650107. Epub 2016 May 30.
8
Effect of Pneumocystis jirovecii pneumonia prophylaxis on hematologic toxicity in patients receiving chemoradiation for primary brain tumors.原发性脑瘤患者放化疗中使用卡泊芬净预防肺孢子菌肺炎对血液学毒性的影响。
J Neurooncol. 2024 Mar;167(1):211-217. doi: 10.1007/s11060-024-04588-4. Epub 2024 Feb 16.
9
Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation.淋巴细胞减少与实体器官移植中迟发性耶氏肺孢子菌肺炎相关。
Transpl Infect Dis. 2018 Jun;20(3):e12876. doi: 10.1111/tid.12876. Epub 2018 Mar 31.
10
Dapsone for Pneumocystis jirovecii pneumonia prophylaxis - applying theory to clinical practice with a focus on drug interactions.氨苯砜预防卡氏肺孢子虫肺炎——关注药物相互作用，将理论应用于临床实践。
Drug Metab Pers Ther. 2020 Jul 20;35(3):dmpt-2019-0018. doi: 10.1515/dmpt-2019-0018.
本文引用的文献
1
Methotrexate as a corticosteroid-sparing agent in leprosy reactions: A French multicenter retrospective study.氨甲蝶呤作为麻风反应中皮质类固醇的辅助药物：一项法国多中心回顾性研究。
PLoS Negl Trop Dis. 2023 Apr 20;17(4):e0011238. doi: 10.1371/journal.pntd.0011238. eCollection 2023 Apr.
2
Pneumocystis jirovecii: a review with a focus on prevention and treatment.卡氏肺孢子虫：预防与治疗为重点的综述
Expert Opin Pharmacother. 2021 Aug;22(12):1579-1592. doi: 10.1080/14656566.2021.1915989. Epub 2021 Apr 19.
3
Use of methotrexate for leprosy reactions. Experience of a referral center and systematic review of the literature.氨苯砜治疗麻风反应的疗效。一家转诊中心的经验及文献系统评价。
Travel Med Infect Dis. 2020 Sep-Oct;37:101670. doi: 10.1016/j.tmaid.2020.101670. Epub 2020 Apr 14.
4
Prophylaxis for Pneumocystis jiroveci pneumonia: is it a necessity in pulmonary patients on high-dose, chronic corticosteroid therapy without AIDS?耶氏肺孢子菌肺炎的预防：对于未患艾滋病但接受大剂量慢性糖皮质激素治疗的肺部疾病患者而言，这有必要吗？
Expert Rev Respir Med. 2015 Apr;9(2):171-81. doi: 10.1586/17476348.2015.1002471.
5
Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?对于病毒学抑制的 HIV 感染且 CD4 细胞计数<200 个/μL 的患者，停止原发性卡氏肺孢子虫肺炎预防是否安全？
Clin Infect Dis. 2010 Sep 1;51(5):611-9. doi: 10.1086/655761.
6
Toxicity and efficacy of daily dapsone as Pneumocystis jiroveci prophylaxis after hematopoietic stem cell transplantation: a case-control study.造血干细胞移植后每日使用氨苯砜预防耶氏肺孢子菌感染的毒性和疗效：一项病例对照研究。
Biol Blood Marrow Transplant. 2005 Jul;11(7):521-9. doi: 10.1016/j.bbmt.2005.04.011.
7
Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy.无获得性免疫缺陷综合征患者的卡氏肺孢子虫肺炎：相关疾病及既往皮质类固醇治疗情况
Mayo Clin Proc. 1996 Jan;71(1):5-13. doi: 10.4065/71.1.5.
8
A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.三种抗肺孢子菌药物用于晚期人类免疫缺陷病毒感染患者的随机试验。美国国立过敏与传染病研究所艾滋病临床试验组。
N Engl J Med. 1995 Mar 16;332(11):693-9. doi: 10.1056/NEJM199503163321101.
9
Use of trimethoprim-sulfamethoxazole in a glucose-6-phosphate dehydrogenase-deficient population.葡萄糖-6-磷酸脱氢酶缺乏人群中复方新诺明的使用。
Rev Infect Dis. 1987 Mar-Apr;9 Suppl 2:S218-29. doi: 10.1093/clinids/9.supplement_2.s218.
10
The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group.感染1型人类免疫缺陷病毒的男性患卡氏肺孢子虫肺炎的风险。多中心艾滋病队列研究组。
N Engl J Med. 1990 Jan 18;322(3):161-5. doi: 10.1056/NEJM199001183220304.
Zotero 插件